Examples of 'canakinumab' in a sentence
Meaning of "canakinumab"
Canakinumab is a noun that refers to a drug used to treat inflammatory conditions and diseases like rheumatoid arthritis
Show more definitions
- A human monoclonal antibody targeted at interleukin-1 beta, intended to treat rheumatoid arthritis.
How to use "canakinumab" in a sentence
Basic
Advanced
canakinumab
It is unknown whether canakinumab is excreted in human milk.
Ilaris contains the active substance canakinumab.
Canakinumab is associated with an increased incidence of serious infections.
Hypersensitivity reactions with canakinumab therapy have been reported.
Canakinumab should not be administered during an active infection.
Ilaris is a medicine that contains the active substance canakinumab.
Canakinumab did not reduce lipid levels from baseline.
Formal carcinogenicity studies have not been conducted with canakinumab.
Canakinumab works by decreasing chronic inflammation.
The active substance is canakinumab.
Canakinumab is used with the guidance and supervision of a doctor.
Malignancy events have been reported in patients treated with canakinumab.
The causal relationship of canakinumab to these events can not be excluded.
Cancer deaths were also halved in those treated with canakinumab.
Canakinumab for the treatment of active systemic juvenile idiopathic arthritis.
See also
There is a limited amount of data from the use of canakinumab in pregnant women.
Canakinumab is a subcutaneous injection.
Formal studies of the potential effect of canakinumab on human fertility have not been conducted.
Canakinumab Novartis is a medicine that contains the active substance canakinumab.
Animal studies indicate that canakinumab crosses the placenta and is detectable in the foetus.
The absolute bioavailability of subcutaneously administered canakinumab was estimated to be 66.
Treatment with canakinumab should not be initiated in patients with neutropenia or leukopenia.
Avoid injecting into scar-tissue as this may lead to insufficient exposure to canakinumab.
Interactions between canakinumab and other medicinal products have not been investigated in formal studies.
Patients who do not respond to initial treatment should not be re-treated with canakinumab.
EPAR of canakinumab.
Canakinumab is a fully humanised monoclonal antibody specifically targeted against IL-1β.
In addition, no antibodies to canakinumab were detected in these studies.
Canakinumab should be used as an on-demand therapy to treat gouty arthritis attacks.
The mean change in pain score among canakinumab treated patients was consistent at day 29.
Canakinumab is used to treat certain types of periodic fever syndromes, sometimes called auto-inflammatory syndromes.
No non-specific tissue cross-reactivity was demonstrated when canakinumab was applied to normal human tissues.
The safety profile of canakinumab appeared similar to that in patients aged 2 years and above.
One was a safety, tolerability, and efficacy study of canakinumab in patients with CAPS.
What was canakinumab Novartis expected to be used for?
Other medicines that block interleukin-1, such as anakinra or canakinumab.
For the primary efficacy endpoint, canakinumab was superior to placebo for all three disease cohorts.
Canakinumab had no effect on male fertility parameters in marmosets C. jacchus.
The distribution volume ( Vss ) of canakinumab varied according to body weight.
Canakinumab also reduced the risk of subsequent attacks ( see Table 5 ).
By attaching to IL-1 beta, canakinumab blocks its activity and reduces inflammation.
Ilaris 150 mg powder and solvent for solution for injection Canakinumab.
In clinical studies, canakinumab has been safely administered with ULT.
I and leukopenia have been observed with medicinal products that inhibit IL-1, including canakinumab.
Next Article » Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows.
The apparent clearance ( CI / F ) of canakinumab increases with body weight.
After reconstitution, each ml of solution contains 150 mg canakinumab.
How does canakinumab Novartis work?
Each ml of solution contains 150 mg canakinumab.
What is canakinumab Novartis?
